Skip Navigation

This Article
Right arrow Abstract
Right arrow FREE Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Right arrow Disclaimer

Risk factors for breakthrough invasive fungal infection during secondary prophylaxis
J. Antimicrob. Chemother. Cornely et al. 61: 939

Supplementary Data

Supplementary Data

Files in this Data Supplement:



This Article
Right arrow Abstract
Right arrow FREE Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Right arrow Disclaimer